Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 10Uterine Cervical Neoplasms 6Vulvar Neoplasms 3Herpes Zoster 3Condylomata Acuminata 3Anus Neoplasms 3Vaginal Neoplasms 2Uterine Cervical Dysplasia 2Whooping Cough 1Tetanus 1Persistent Infection 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Neoplasm Metastasis 1Meningitis 1High Grade Cervical Intraepithelial Neoplasia 1Hematologic Neoplasms 1Diphtheria 1

Interventions

Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Persistent Infection × Vaccines × Clear all
NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Xiamen Innovax Biotech Co., Ltd

Phase 4 Completed
540 enrolled
Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡